The value of the total investment in Flexion Therapeutics, Inc. went from $15,000 to $57,000 increasing 280.0% since the last quarter. It is focused on the development and commercialization of injectable pain therapies. The Business's portfolio of product candidates addresses the OA pain treatment spectrum, from moderate to severe pain.
In terms of EBITDA Yield, Flexion Therapeutics, Inc.
A number of other analysts have also commented on FLXN. Needham & Company LLC reiterated a buy rating and set a $36.00 target price (up previously from $34.00) on shares of Flexion Therapeutics in a research report on Thursday, August 10th. Zacks Investment Research cut shares of Flexion Therapeutics from a "hold" rating to a "sell" rating in a research report on Tuesday, August 22nd. Next quarter's EPS is estimated at $-1.15 with next year's EPS anticipated to be $-3.49. Cantor Fitzgerald set a $40.00 target price on shares of Flexion Therapeutics and gave the company a buy rating in a research report on Monday, June 12th.
Looking at some ROIC (Return on Invested Capital) numbers, Flexion Therapeutics, Inc. (NasdaqGM:FLXN) is -1.41163. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The stock presently has an average rating of Buy and a consensus target price of $88.50. Trading volume was up 572.61% over the stocks average daily volume. The company's market capitalization is $854.10 million. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return. (NasdaqGM:FLXN) is -0.098078. This is calculated by taking the earnings per share and dividing it by the last closing share price.
In the last earnings report the EPS was $-3.11 and is expected to be $-3.77 for the current year with 31,905,000 shares now outstanding.
Trading volume for Flexion Therapeutics, Inc. was 4,332K in the last trading session.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was illegally stolen and reposted in violation of USA and global trademark and copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/12/laidlaw-reiterates-buy-rating-for-flexion-therapeutics-inc-flxn.html.
Insider Trades for Flexion Therapeutics, Inc. show that the latest trade was made on 4 Sep 2017 where Deniz (Yamo M.D.), the Officer completed a transaction type "Buy" in which 1000 shares were traded at a price of $24.2. The shares were acquired at an average cost of $24.15 per share, for a total transaction of $72,450.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.
The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.
Institutional investors and hedge funds have recently modified their holdings of the stock. Fiduciary Trust Co. purchased a new stake in shares of Flexion Therapeutics in the 2nd quarter worth about $101,000.
Flexion Therapeutics, Inc., launched on November 5, 2007, is a specialty pharmaceutical company. IFP Advisors Inc now owns 5,080 shares of the specialty pharmaceutical company's stock worth $103,000 after purchasing an additional 1,000 shares during the period. As of the end of the quarter Raymond James Financial Services Advisors, Inc. had acquired a total of 7,667 shares growing its position 13.7%. Advisor Group Inc. now owns 5,200 shares of the specialty pharmaceutical company's stock valued at $105,000 after purchasing an additional 3,500 shares during the last quarter. Finally, Voya Investment Management LLC raised its holdings in shares of Flexion Therapeutics by 25.8% in the second quarter.
RBC Capital Markets initiated Marinus Pharmaceuticals Inc (NASDAQ:MRNS) on Thursday, December 17 with "Outperform" rating. The company reported $1.11 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.06.
The upgraded version of Bixby is set to be announced at Samsung's annual Developer Conference in San Francisco on October 18. For many users, Bixby was soon associated with accidental button presses and annoyance.
Additionally Caterpillar, Inc . recently declared a dividend for shareholders which was paid on Saturday the 19th of August 2017. The industrial products company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23.
Senior Congress leader and Leader of Opposition in TSLC Mohammed Ali Shabbir congratulated former Maharashtra Chief Minister. The results also marked Muslim community's rejection of the Owaisi brothers and the All India Majlis-e-Itehadul Muslimeen.
Dominion Energy Inc (NYSE:DCUC) was reduced too. $207,404 worth of Msci Inc (NYSE:MSCI) shares were sold by Pettit CD Baer . Papp L Roy & Associates increased Johnson & Johnson (NYSE:JNJ) stake by 5,145 shares to 85,389 valued at $11.30M in 2017Q2.
Pacific Crest reiterated an "equal weight" rating on shares of Advanced Micro Devices in a research note on Tuesday, June 20th. ING Groep NV purchased a new position in Advanced Micro Devices during the first quarter valued at approximately $127,000.
Supreme Court to address whether a law banning sex discrimination in the workplace provides protections to gay employees. Jameka Evans, who worked at Georgia Regional Hospital at Savannah from 2012 to 2013, ultimately left her job and sued.
Almas countered a Gargano kick on the apron with a kick of his own, followed by a backbreaker and reverse DDT on the apron. Basically, take everything you read from this point forward with a grain of salt as its credibility is preposterously low.
Hall, a junior who lived at the fraternity house, is in a "deep depression" over his friend's death, his attorney said. Hazing is a misdemeanor crime, but it could result in expulsion from LSU and up to 30 days in jail for the suspects.
The expected COG's profit could reach $51.32M giving the stock 59.14 P/E in the case that $0.11 earnings per share is reported. It has underperformed by 15.45% the S&P500.The move comes after 5 months positive chart setup for the $12.13 billion company.
Finally, Louisiana State Employees Retirement System lifted its position in shares of AMC Networks by 1.4% during the 2nd quarter. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.
AIADMK Leader Sasikala's Five Days Parole Ends
She named newborns babies of party workers during her hospital visits by halting her vehicle on the way of Hospital. While granting bail, the court had directed her to keep away from all political activity during the parole period.
Drug overdose deaths in BC have surpassed 2016 total: coroner
In most cases, the report said, fentanyl was combined with other illicit drugs, such as cocaine, heroin and methamphetamines. Vancouver saw 255 deaths between January and August, the highest of any municipality in the province by at least 132 deaths.
Quake recorded near North Korea's nuclear test site
Today (Thursday), a relatively weak 2.9 magnitude natural disaster was recorded near the North Korean town of Sungjibaegam. Geological Survey recorded a small quake in an area of North Korea where previous nuclear tests have been carried out.
Traders Sell Anheuser-Busch Inbev SA (BUD) on Strength (BUD)
As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) has "Buy" rating given on Friday, September 1 by RBC Capital Markets.
Producer Prices Grew 0.4% in September
However, the producer price (PPI) uptick was largely a result of higher energy costs in the wake of Hurricane Harvey. A plunge in energy prices caused producer prices to fall in 2015 and hold flat most of previous year .